JPMORGAN CHASE & CO - CONNECT BIOPHARMA HLDGS LTD ownership

CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 30 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CONNECT BIOPHARMA HLDGS LTD
ValueSharesWeighting
Q3 2023$18,249
-66.0%
23,532
-51.4%
0.00%
Q2 2023$53,693
-32.0%
48,372
-38.4%
0.00%
Q1 2023$79,000
+1974900.0%
78,547
+1312.7%
0.00%
Q4 2022$4
-99.9%
5,560
+81.1%
0.00%
Q3 2022$4,0003,070
+1118.3%
0.00%
Q2 2022$0
-100.0%
252
-93.6%
0.00%
Q1 2022$12,000
-20.0%
3,920
+36.7%
0.00%
Q4 2021$15,0002,8680.00%
Other shareholders
CONNECT BIOPHARMA HLDGS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 597,678$771,0000.24%
Kynam Capital Management, LP 739,649$954,0000.20%
RA Capital Management 6,991,003$9,018,0000.19%
Octagon Capital Advisors LP 450,000$581,0000.10%
Ikarian Capital, LLC 219,501$283,0000.06%
UBS OCONNOR LLC 613,931$792,000,0000.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,277,519$1,648,0000.00%
ROCKY MOUNTAIN ADVISERS, LLC 1,200$2,0000.00%
CSS LLC/IL 38,721$50,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 26,867$35,0000.00%
View complete list of CONNECT BIOPHARMA HLDGS LTD shareholders